Contact Lenses News:
LAKE ZURICH, Ill.—Services are planned for long-time contact lens and marketing executive, Thomas F. Steiner, 73, who passed away on Dec. 6 after a long illness. Steiner spent 35 years as a visionary marketing executive in the optical industry with Wesley Jessen and CIBA Vision, and later started a business as a marketing consultant. Among his many accomplishments was his involvement in the launch of cosmetic color contact lenses, and the creation of several unique strategic programs for educati...
MULLICA HILL, N.J—OcuMedic, Inc., the first developer of therapeutic lens for the delivery of drugs for the global ophthalmic market, announced their Contact Drug Delivery System, received a patent by the European Patent Offices, according to a release from the company. The patent will cover all intellectual property of the company’s timed-released delivery of drugs directly to the eye through prescription soft-contact lenses. President and CEO of OcuMedic, Inc., Keith D. Ignotz, said, “The Euro...
FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....
NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...
FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....
CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....